After U.S. approval, Fresenius to complete $2B buy of NxStage 'within days'

The acquisition of Lawrence-based NxStage Medical Inc. by Germany-based Fresenius Medical Care has been approved by the U.S. Federal Trade Commission, according to Reuters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.